| 1 | [SID26748889] | Active | Potency | 0.3981 | qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1) [AID2517, Type: confirmatory] | Chain A, Human Ape1 Endonuclease With Bound Abasic Dna And Mn2+ Ion [gi:6980812] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 26748889 | | CID | 16757835 | | Outcome | Active | | Potency | 0.3981 [uM] | | BioAssay | qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1) | | AID | 2517 | | BioAssay type | confirmatory | | Target | Chain A, Human Ape1 Endonuclease With Bound Abasic Dna And Mn2+ Ion [gi:6980812] | | PubMed | | | Data Table |  |
|
| 2 | [SID26748889] | Active | Potency | 0.5623 | qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia: Hit Validation [AID504374, Type: confirmatory] | core-binding factor subunit beta isoform 2 [Homo sapiens] [gi:13124873] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 26748889 | | CID | 16757835 | | Outcome | Active | | Potency | 0.5623 [uM] | | BioAssay | qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia: Hit Validation | | AID | 504374 | | BioAssay type | confirmatory | | Target | core-binding factor subunit beta isoform 2 [Homo sapiens] [gi:13124873] | | PubMed | | | Data Table |  |
|
| 3 | [SID26748889] | Active | Potency | 0.5623 | qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia: Hit Validation [AID504374, Type: confirmatory] | core-binding factor subunit beta isoform 2 [Homo sapiens] [gi:13124873] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 26748889 | | CID | 16757835 | | Outcome | Active | | Potency | 0.5623 [uM] | | BioAssay | qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia: Hit Validation | | AID | 504374 | | BioAssay type | confirmatory | | Target | core-binding factor subunit beta isoform 2 [Homo sapiens] [gi:13124873] | | PubMed | | | Data Table |  |
|
| 4 | [SID26748889] | Active | Potency | 0.7079 | Confirmation qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1) [AID2572, Type: confirmatory] | Chain A, Human Ape1 Endonuclease With Bound Abasic Dna And Mn2+ Ion [gi:6980812] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 26748889 | | CID | 16757835 | | Outcome | Active | | Potency | 0.7079 [uM] | | BioAssay | Confirmation qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1) | | AID | 2572 | | BioAssay type | confirmatory | | Target | Chain A, Human Ape1 Endonuclease With Bound Abasic Dna And Mn2+ Ion [gi:6980812] | | PubMed | | | Data Table |  |
|
| 5 | [SID26748889] | Active | Potency | 0.8913 | qHTS for Inhibitors of Polymerase Kappa [AID588579, Type: confirmatory] | DNA polymerase kappa [Homo sapiens] [gi:7705344] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 26748889 | | CID | 16757835 | | Outcome | Active | | Potency | 0.8913 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Kappa | | AID | 588579 | | BioAssay type | confirmatory | | Target | DNA polymerase kappa [Homo sapiens] [gi:7705344] | | PubMed | | | Data Table |  |
|
| 6 | [SID26748889] | Active | Potency | 0.8913 | qHTS for Inhibitors of Polymerase Kappa [AID588579, Type: confirmatory] | DNA polymerase kappa [Homo sapiens] [gi:7705344] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 26748889 | | CID | 16757835 | | Outcome | Active | | Potency | 0.8913 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Kappa | | AID | 588579 | | BioAssay type | confirmatory | | Target | DNA polymerase kappa [Homo sapiens] [gi:7705344] | | PubMed | | | Data Table |  |
|
| 7 | [SID26748889] | Active | Potency | 1.7783 | qHTS Assay for Inhibitors of GCN5L2 [AID504327, Type: confirmatory] | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 26748889 | | CID | 16757835 | | Outcome | Active | | Potency | 1.7783 [uM] | | BioAssay | qHTS Assay for Inhibitors of GCN5L2 | | AID | 504327 | | BioAssay type | confirmatory | | Target | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] | | PubMed | | | Data Table |  |
|
| 8 | [SID26748889] | Active | Potency | 1.7783 | qHTS Assay for Inhibitors of GCN5L2 [AID504327, Type: confirmatory] | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 26748889 | | CID | 16757835 | | Outcome | Active | | Potency | 1.7783 [uM] | | BioAssay | qHTS Assay for Inhibitors of GCN5L2 | | AID | 504327 | | BioAssay type | confirmatory | | Target | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] | | PubMed | | | Data Table |  |
|
| 9 | [SID26748889] | Active | Potency | 1.9953 | qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1) [AID2549, Type: confirmatory] | Chain A, Structure Of Human Recq-Like Helicase In Complex With A Dna Substrate [gi:282403581] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 26748889 | | CID | 16757835 | | Outcome | Active | | Potency | 1.9953 [uM] | | BioAssay | qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1) | | AID | 2549 | | BioAssay type | confirmatory | | Target | Chain A, Structure Of Human Recq-Like Helicase In Complex With A Dna Substrate [gi:282403581] | | PubMed | | | Data Table |  |
|
| 10 | [SID26748889] | Active | Potency | 2.5119 | qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia: Hit Validation with Orthogonal Assay [AID504375, Type: confirmatory] | core-binding factor subunit beta isoform 2 [Homo sapiens] [gi:13124873] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 26748889 | | CID | 16757835 | | Outcome | Active | | Potency | 2.5119 [uM] | | BioAssay | qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia: Hit Validation with Orthogonal Assay | | AID | 504375 | | BioAssay type | confirmatory | | Target | core-binding factor subunit beta isoform 2 [Homo sapiens] [gi:13124873] | | PubMed | | | Data Table |  |
|
| 11 | [SID26748889] | Active | Potency | 2.5119 | qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia: Hit Validation with Orthogonal Assay [AID504375, Type: confirmatory] | core-binding factor subunit beta isoform 2 [Homo sapiens] [gi:13124873] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 26748889 | | CID | 16757835 | | Outcome | Active | | Potency | 2.5119 [uM] | | BioAssay | qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia: Hit Validation with Orthogonal Assay | | AID | 504375 | | BioAssay type | confirmatory | | Target | core-binding factor subunit beta isoform 2 [Homo sapiens] [gi:13124873] | | PubMed | | | Data Table |  |
|
| 12 | [SID26748889] | Active | Potency | 2.8184 | Confirmation qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1) [AID2708, Type: confirmatory] | Chain A, Structure Of Human Recq-Like Helicase In Complex With A Dna Substrate [gi:282403581] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 26748889 | | CID | 16757835 | | Outcome | Active | | Potency | 2.8184 [uM] | | BioAssay | Confirmation qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1) | | AID | 2708 | | BioAssay type | confirmatory | | Target | Chain A, Structure Of Human Recq-Like Helicase In Complex With A Dna Substrate [gi:282403581] | | PubMed | | | Data Table |  |
|
| 13 | [SID26748889] | Active | Potency | 3.1623 | qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4 [AID893, Type: confirmatory] | Chain A, The Structure Of Wild-Type Human Hadh2 (17beta- Hydroxysteroid Dehydrogenase Type 10) Bound [gi:122921310] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 26748889 | | CID | 16757835 | | Outcome | Active | | Potency | 3.1623 [uM] | | BioAssay | qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4 | | AID | 893 | | BioAssay type | confirmatory | | Target | Chain A, The Structure Of Wild-Type Human Hadh2 (17beta- Hydroxysteroid Dehydrogenase Type 10) Bound [gi:122921310] | | PubMed | | | Data Table |  |
|
| 14 | [SID26748889] | Active | Potency | 3.1623 | qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM) [AID2528, Type: confirmatory] | Bloom syndrome protein [Homo sapiens] [gi:4557365] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 26748889 | | CID | 16757835 | | Outcome | Active | | Potency | 3.1623 [uM] | | BioAssay | qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM) | | AID | 2528 | | BioAssay type | confirmatory | | Target | Bloom syndrome protein [Homo sapiens] [gi:4557365] | | PubMed | | | Data Table |  |
|
| 15 | [SID26748889] | Active | Potency | 6.3096 | qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Red Fluorophore) [AID892, Type: confirmatory] | Chain A, Solution Structure Of The Brct-C Domain From Human Brca1 [gi:159162802] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 26748889 | | CID | 16757835 | | Outcome | Active | | Potency | 6.3096 [uM] | | BioAssay | qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Red Fluorophore) | | AID | 892 | | BioAssay type | confirmatory | | Target | Chain A, Solution Structure Of The Brct-C Domain From Human Brca1 [gi:159162802] | | PubMed | | | Data Table |  |
|
| 16 | [SID26748889] | Active | Potency | 7.0795 | Counterscreen for RECQ1 Inhibitors: ADP Fluorescence Polarization Displacement Assay [AID2711, Type: confirmatory] | |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 26748889 | | CID | 16757835 | | Outcome | Active | | Potency | 7.0795 [uM] | | BioAssay | Counterscreen for RECQ1 Inhibitors: ADP Fluorescence Polarization Displacement Assay | | AID | 2711 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 17 | [SID26748889] | Active | Potency | 7.0795 | Counterscreen for BLMA Inhibitors: ADP Fluorescence Polarization Displacement Assay [AID2712, Type: confirmatory] | |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 26748889 | | CID | 16757835 | | Outcome | Active | | Potency | 7.0795 [uM] | | BioAssay | Counterscreen for BLMA Inhibitors: ADP Fluorescence Polarization Displacement Assay | | AID | 2712 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 18 | [SID26748889] | Active | Potency | 7.9433 | qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase) [AID894, Type: confirmatory] | 15-hydroxyprostaglandin dehydrogenase [NAD+] isoform 1 [Homo sapiens] [gi:31542939] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 26748889 | | CID | 16757835 | | Outcome | Active | | Potency | 7.9433 [uM] | | BioAssay | qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase) | | AID | 894 | | BioAssay type | confirmatory | | Target | 15-hydroxyprostaglandin dehydrogenase [NAD+] isoform 1 [Homo sapiens] [gi:31542939] | | PubMed | | | Data Table |  |
|
| 19 | [SID26748889] | Active | Potency | 7.9433 | qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase) [AID894, Type: confirmatory] | 15-hydroxyprostaglandin dehydrogenase [NAD+] isoform 1 [Homo sapiens] [gi:31542939] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 26748889 | | CID | 16757835 | | Outcome | Active | | Potency | 7.9433 [uM] | | BioAssay | qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase) | | AID | 894 | | BioAssay type | confirmatory | | Target | 15-hydroxyprostaglandin dehydrogenase [NAD+] isoform 1 [Homo sapiens] [gi:31542939] | | PubMed | | | Data Table |  |
|
| 20 | [SID26748889] | Active | Potency | 7.9433 | qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase) [AID894, Type: confirmatory] | 15-hydroxyprostaglandin dehydrogenase [NAD+] isoform 1 [Homo sapiens] [gi:31542939] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 26748889 | | CID | 16757835 | | Outcome | Active | | Potency | 7.9433 [uM] | | BioAssay | qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase) | | AID | 894 | | BioAssay type | confirmatory | | Target | 15-hydroxyprostaglandin dehydrogenase [NAD+] isoform 1 [Homo sapiens] [gi:31542939] | | PubMed | | | Data Table |  |
|
| 21 | [SID26748889] | Active | Potency | 10 | qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-7 [AID889, Type: confirmatory] | Caspase-7 [gi:1730092] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 26748889 | | CID | 16757835 | | Outcome | Active | | Potency | 10 [uM] | | BioAssay | qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-7 | | AID | 889 | | BioAssay type | confirmatory | | Target | Caspase-7 [gi:1730092] | | PubMed | | | Data Table |  |
|
| 22 | [SID26748889] | Active | Potency | 10 | qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-7 [AID889, Type: confirmatory] | Caspase-7 [gi:1730092] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 26748889 | | CID | 16757835 | | Outcome | Active | | Potency | 10 [uM] | | BioAssay | qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-7 | | AID | 889 | | BioAssay type | confirmatory | | Target | Caspase-7 [gi:1730092] | | PubMed | | | Data Table |  |
|
| 23 | [SID26748889] | Active | Potency | 10 | qHTS Assay for Inhibitors of 15-hLO-2 (15-human lipoxygenase 2) [AID881, Type: confirmatory] | Arachidonate 15-lipoxygenase B [gi:317373425] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 26748889 | | CID | 16757835 | | Outcome | Active | | Potency | 10 [uM] | | BioAssay | qHTS Assay for Inhibitors of 15-hLO-2 (15-human lipoxygenase 2) | | AID | 881 | | BioAssay type | confirmatory | | Target | Arachidonate 15-lipoxygenase B [gi:317373425] | | PubMed | | | Data Table |  |
|
| 24 | [SID26748889] | Active | Potency | 10 | Inhibitors of USP1/UAF1: Pilot qHTS [AID504865, Type: confirmatory] | USP1 protein [Homo sapiens] [gi:118600387] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 26748889 | | CID | 16757835 | | Outcome | Active | | Potency | 10 [uM] | | BioAssay | Inhibitors of USP1/UAF1: Pilot qHTS | | AID | 504865 | | BioAssay type | confirmatory | | Target | USP1 protein [Homo sapiens] [gi:118600387] | | PubMed | | | Data Table |  |
|
| 25 | [SID26748889] | Active | Potency | 11.2202 | qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E) [AID2147, Type: confirmatory] | Chain A, Crystal Structure Of The Human 2-Oxoglutarate Oxygenase Loc390245 [gi:221046486] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 26748889 | | CID | 16757835 | | Outcome | Active | | Potency | 11.2202 [uM] | | BioAssay | qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E) | | AID | 2147 | | BioAssay type | confirmatory | | Target | Chain A, Crystal Structure Of The Human 2-Oxoglutarate Oxygenase Loc390245 [gi:221046486] | | PubMed | | | Data Table |  |
|
| 26 | [SID26748889] | Active | Potency | 12.5893 | qHTS Assay for Inhibitors of 15-hLO (15-human lipoxygenase) [AID887, Type: confirmatory] | 15-lipoxygenase [Homo sapiens] [gi:1832253] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 26748889 | | CID | 16757835 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | qHTS Assay for Inhibitors of 15-hLO (15-human lipoxygenase) | | AID | 887 | | BioAssay type | confirmatory | | Target | 15-lipoxygenase [Homo sapiens] [gi:1832253] | | PubMed | | | Data Table |  |
|
| 27 | [SID26748889] | Active | Potency | 12.5893 | qHTS Assay for Inhibitors of 15-hLO (15-human lipoxygenase) [AID887, Type: confirmatory] | 15-lipoxygenase [Homo sapiens] [gi:1832253] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 26748889 | | CID | 16757835 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | qHTS Assay for Inhibitors of 15-hLO (15-human lipoxygenase) | | AID | 887 | | BioAssay type | confirmatory | | Target | 15-lipoxygenase [Homo sapiens] [gi:1832253] | | PubMed | | | Data Table |  |
|
| 28 | [SID26748889] | Active | Potency | 12.5893 | qHTS Assay for Inhibitors of Ubiquitin-specific Protease USP2a [AID927, Type: confirmatory] | ubiquitin carboxyl-terminal hydrolase 2 isoform a [Homo sapiens] [gi:188528692] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 26748889 | | CID | 16757835 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | qHTS Assay for Inhibitors of Ubiquitin-specific Protease USP2a | | AID | 927 | | BioAssay type | confirmatory | | Target | ubiquitin carboxyl-terminal hydrolase 2 isoform a [Homo sapiens] [gi:188528692] | | PubMed | | | Data Table |  |
|
| 29 | [SID26748889] | Active | Potency | 12.5893 | qHTS Assay for Inhibitors of Ubiquitin-specific Protease USP2a [AID927, Type: confirmatory] | ubiquitin carboxyl-terminal hydrolase 2 isoform a [Homo sapiens] [gi:188528692] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 26748889 | | CID | 16757835 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | qHTS Assay for Inhibitors of Ubiquitin-specific Protease USP2a | | AID | 927 | | BioAssay type | confirmatory | | Target | ubiquitin carboxyl-terminal hydrolase 2 isoform a [Homo sapiens] [gi:188528692] | | PubMed | | | Data Table |  |
|
| 30 | [SID26748889] | Active | Potency | 15.8489 | qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent) [AID1478, Type: confirmatory] | Chain A, Crystal Structure Of Cruzain Covalently Bound To A Purine Nitrile [gi:281307097] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 26748889 | | CID | 16757835 | | Outcome | Active | | Potency | 15.8489 [uM] | | BioAssay | qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent) | | AID | 1478 | | BioAssay type | confirmatory | | Target | Chain A, Crystal Structure Of Cruzain Covalently Bound To A Purine Nitrile [gi:281307097] | | PubMed | | | Data Table |  |
|
| 31 | [SID26748889] | Active | Potency | 16.1366 | Biochemical firefly luciferase enzyme assay for NPC [AID624030, Type: confirmatory] | Luciferase [Photinus pyralis] [gi:160794] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 26748889 | | CID | 16757835 | | Outcome | Active | | Potency | 16.1366 [uM] | | BioAssay | Biochemical firefly luciferase enzyme assay for NPC | | AID | 624030 | | BioAssay type | confirmatory | | Target | Luciferase [Photinus pyralis] [gi:160794] | | PubMed | | | Data Table |  |
|
| 32 | [SID26748889] | Active | Potency | 17.7407 | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia [AID2451, Type: confirmatory] | Chain A, Structure Of Giardia Fructose-1,6-Biphosphate Aldolase In Complex With Phosphoglycolohydrox [gi:122920737] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 26748889 | | CID | 16757835 | | Outcome | Active | | Potency | 17.7407 [uM] | | BioAssay | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia | | AID | 2451 | | BioAssay type | confirmatory | | Target | Chain A, Structure Of Giardia Fructose-1,6-Biphosphate Aldolase In Complex With Phosphoglycolohydrox [gi:122920737] | | PubMed | | | Data Table |  |
|
| 33 | [SID26748889] | Active | Potency | 22.3872 | qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding [AID1460, Type: confirmatory] | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 26748889 | | CID | 16757835 | | Outcome | Active | | Potency | 22.3872 [uM] | | BioAssay | qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding | | AID | 1460 | | BioAssay type | confirmatory | | Target | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] | | PubMed | | | Data Table |  |
|
| 34 | [SID26748889] | Active | Potency | 22.3872 | qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding [AID1460, Type: confirmatory] | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 26748889 | | CID | 16757835 | | Outcome | Active | | Potency | 22.3872 [uM] | | BioAssay | qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding | | AID | 1460 | | BioAssay type | confirmatory | | Target | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] | | PubMed | | | Data Table |  |
|
| 35 | [SID26748889] | Active | Potency | 22.3872 | Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2 [AID1479, Type: confirmatory] | thyroid hormone receptor beta [Homo sapiens] [gi:189491771] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 26748889 | | CID | 16757835 | | Outcome | Active | | Potency | 22.3872 [uM] | | BioAssay | Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2 | | AID | 1479 | | BioAssay type | confirmatory | | Target | thyroid hormone receptor beta [Homo sapiens] [gi:189491771] | | PubMed | | | Data Table |  |
|
| 36 | [SID26748889] | Active | Potency | 22.3872 | Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2 [AID1479, Type: confirmatory] | thyroid hormone receptor beta [Homo sapiens] [gi:189491771] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 26748889 | | CID | 16757835 | | Outcome | Active | | Potency | 22.3872 [uM] | | BioAssay | Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2 | | AID | 1479 | | BioAssay type | confirmatory | | Target | thyroid hormone receptor beta [Homo sapiens] [gi:189491771] | | PubMed | | | Data Table |  |
|
| 37 | [SID26748889] | Active | Potency | 22.3872 | Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2 [AID1479, Type: confirmatory] | thyroid hormone receptor beta [Homo sapiens] [gi:189491771] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 26748889 | | CID | 16757835 | | Outcome | Active | | Potency | 22.3872 [uM] | | BioAssay | Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2 | | AID | 1479 | | BioAssay type | confirmatory | | Target | thyroid hormone receptor beta [Homo sapiens] [gi:189491771] | | PubMed | | | Data Table |  |
|
| 38 | [SID26748889] | Active | Potency | 25.1189 | qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1 [AID900, Type: confirmatory] | caspase-1 isoform alpha precursor [Homo sapiens] [gi:15431328] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 26748889 | | CID | 16757835 | | Outcome | Active | | Potency | 25.1189 [uM] | | BioAssay | qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1 | | AID | 900 | | BioAssay type | confirmatory | | Target | caspase-1 isoform alpha precursor [Homo sapiens] [gi:15431328] | | PubMed | | | Data Table |  |
|
| 39 | [SID26748889] | Active | Potency | 25.1189 | qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1 [AID900, Type: confirmatory] | caspase-1 isoform alpha precursor [Homo sapiens] [gi:15431328] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 26748889 | | CID | 16757835 | | Outcome | Active | | Potency | 25.1189 [uM] | | BioAssay | qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1 | | AID | 900 | | BioAssay type | confirmatory | | Target | caspase-1 isoform alpha precursor [Homo sapiens] [gi:15431328] | | PubMed | | | Data Table |  |
|
| 40 | [SID26748889] | Active | Potency | 39.8107 | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 26748889 | | CID | 16757835 | | Outcome | Active | | Potency | 39.8107 [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 41 | [SID26748889] | Active | Potency | 39.8107 | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 26748889 | | CID | 16757835 | | Outcome | Active | | Potency | 39.8107 [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 42 | [SID26748889] | Active | Potency | 39.8107 | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 26748889 | | CID | 16757835 | | Outcome | Active | | Potency | 39.8107 [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 43 | [SID26748889] | Active | Potency | 39.8107 | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 26748889 | | CID | 16757835 | | Outcome | Active | | Potency | 39.8107 [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 44 | [SID26748889] | Active | Potency | 56.2341 | qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase) [AID1490, Type: confirmatory] | phosphopantetheinyl transferase [Bacillus subtilis] [gi:10954339] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 26748889 | | CID | 16757835 | | Outcome | Active | | Potency | 56.2341 [uM] | | BioAssay | qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase) | | AID | 1490 | | BioAssay type | confirmatory | | Target | phosphopantetheinyl transferase [Bacillus subtilis] [gi:10954339] | | PubMed | | | Data Table |  |
|
| 45 | [SID26748889] | Active | | | qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore) [AID880, Type: confirmatory] | RGS12 [Homo sapiens] [gi:3290016] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 26748889 | | CID | 16757835 | | Outcome | Active | | BioAssay | qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore) | | AID | 880 | | BioAssay type | confirmatory | | Target | RGS12 [Homo sapiens] [gi:3290016] | | PubMed | | | Data Table |  |
|
| 46 | [SID26748889] | Active | | | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen [AID2472, Type: screening] | glyceraldehyde-3-phosphate dehydrogenase [Homo sapiens] [gi:7669492] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 26748889 | | CID | 16757835 | | Outcome | Active | | BioAssay | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen | | AID | 2472 | | BioAssay type | screening | | Target | glyceraldehyde-3-phosphate dehydrogenase [Homo sapiens] [gi:7669492] | | PubMed | | | Data Table |  |
|
| 47 | [SID26748889] | Active | | | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen [AID2472, Type: screening] | glyceraldehyde-3-phosphate dehydrogenase [Homo sapiens] [gi:7669492] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 26748889 | | CID | 16757835 | | Outcome | Active | | BioAssay | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen | | AID | 2472 | | BioAssay type | screening | | Target | glyceraldehyde-3-phosphate dehydrogenase [Homo sapiens] [gi:7669492] | | PubMed | | | Data Table |  |
|
| 48 | [SID26748889] | Active | | | qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_23, Type: Literature] | |   View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 26748889 | | CID | 16757835 | | Outcome | Active | | BioAssay | qHTS profiling for inhibitors of Plasmodium falciparum proliferation | | AID | 504749 | | BioAssay type | Literature | | Target | | | PubMed | 21817045 | | Data Table |  |
|
| 49 | [SID26748889] | Active | | | qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_20, Type: Literature] | |   View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 26748889 | | CID | 16757835 | | Outcome | Active | | BioAssay | qHTS profiling for inhibitors of Plasmodium falciparum proliferation | | AID | 504749 | | BioAssay type | Literature | | Target | | | PubMed | 21817045 | | Data Table |  |
|
| 50 | [SID26748889] | Unspecified | | | qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749, Type: Literature] | |   View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 26748889 | | CID | 16757835 | | Outcome | Unspecified | | BioAssay | qHTS profiling for inhibitors of Plasmodium falciparum proliferation | | AID | 504749 | | BioAssay type | Literature | | Target | | | PubMed | 21817045 | | Data Table |  |
|